POLIBENESTAR
Institut d' investigació
Universidad de Chile
Santiago de Chile, ChilePublicaciones en colaboración con investigadores/as de Universidad de Chile (10)
2022
-
Diminished Inhibitory Control in Adolescents with Overweight and/or Substance Use: an ERP Study
International Journal of Mental Health and Addiction
2019
-
Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology
Journal of Allergy and Clinical Immunology, Vol. 143, Núm. 3, pp. 864-879
2017
2016
-
ALS-linked protein disulfide isomerase variants cause motor dysfunction
EMBO Journal, Vol. 35, Núm. 8, pp. 845-865
-
ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle
Clinical and Translational Allergy, Vol. 6, Núm. 1
-
Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
Clinical and Translational Allergy, Vol. 6, Núm. 1
2015
-
Functional role of the disulfide isomerase ERp57 in axonal regeneration
PLoS ONE, Vol. 10, Núm. 9
-
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 70, Núm. 11, pp. 1372-1392
-
The protein-disulfide isomerase ERp57 regulates the steady-state levels of the prion protein
Journal of Biological Chemistry, Vol. 290, Núm. 39, pp. 23631-23645